Skip to main content

Sexual Dysfunction

Treatment of genitourinary sexual dysfunction spans a wide spectrum — from first-line oral pharmacotherapy through second-line injectables and intraurethral options to surgical implantation, plaque incision and grafting, and corporal reconstruction. Approach is guided by etiology, severity, comorbidities (particularly diabetes, cardiovascular disease, and prior radiation), partner considerations, and prior treatment history.

The three domains below cover the operative half of the toolkit. The medical-therapy hubs live in Pharmacology — Sexual Medicine & Andrology (PDE5 inhibitors, ICI agents, MUSE, testosterone replacement, androgen adjuncts, Peyronie's plaque-modifying agents, priapism management). For ED of vascular origin, penile-revascularization is a niche reconstructive option in highly selected young patients with focal post-traumatic disease.

  • Erectile DysfunctionPDE5 inhibitors, VED, MUSE, intracavernosal injections, penile implants
  • Penile ImplantsPreop evaluation (CURSED), intraop setup (no-touch), approaches (PS/IP/SC), reservoir placement (SoR/HSM), models database, infection, revision, complications
  • Peyronie's DiseaseDisease phases, pathophysiology, evaluation (ICI test, Doppler), non-surgical therapies (CCH/Xiaflex, interferon, traction), surgical algorithm (plication vs. grafting vs. prosthesis + modeling)